Successful use of a military haemostatic agent in patients undergoing extracorporeal circulatory assistance and delayed sternal closure
Open Access
- 24 February 2012
- journal article
- case report
- Published by Oxford University Press (OUP) in Interactive CardioVascular and Thoracic Surgery
- Vol. 14 (6) , 695-698
Abstract
We report the successful control of bleeding in two patients who underwent post-cardiotomy extracorporeal circulatory support (ECMO) and then developed life-threatening bleeding due to severe coagulopathy. After the failure of conventional techniques, bleeding control was achieved using Celox™ Gauze (MedTrade Products Ltd, Cheshire, UK) packed on the sternal edges and pericardial cavity.Keywords
This publication has 6 references indexed in Scilit:
- Successful use of a military haemostatic agent in patients undergoing extracorporeal circulatory assistance and delayed sternal closureInteractive CardioVascular and Thoracic Surgery, 2012
- Off-label use of recombinant activated factor VII in intractable haemorrhage after cardiovascular surgery: an observational study of practices in 23 French cardiac centres (2005–7)European Journal of Cardio-Thoracic Surgery, 2011
- A New Hemostatic Agent: Initial Life-Saving Experience With Celox (Chitosan) in Cardiothoracic SurgeryThe Annals of Thoracic Surgery, 2009
- Coagulation 2006: A Modern View of HemostasisHematology/Oncology Clinics of North America, 2007
- Is recombinant activated factor VII useful for intractable bleeding after cardiac surgery?Interactive CardioVascular and Thoracic Surgery, 2006
- Proximal aortic dissection with coronary malperfusion: Presentation, management, and outcomeThe Journal of Thoracic and Cardiovascular Surgery, 2001